Evidence map›Paper›PMID 39202815›Full record

ArticleMolecules (Basel, Switzerland)2024

Investigation into the Sonodynamic Activity of Three Newly Synthesized Derivatives of Ciprofloxacin.

Ying Zheng, Jing Lv, Jun Zhang, Yu Liu, Xiaofang Wang, Bin Liu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ying ZhengArtemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID 0000-0001-7455-0951
Jing LvSchool of Pharmaceutical Sciences, Liaoning University, Shenyang 110036, China.
Jun ZhangSchool of Pharmaceutical Sciences, Liaoning University, Shenyang 110036, China.
Yu LiuSchool of Pharmaceutical Sciences, Liaoning University, Shenyang 110036, China.
Xiaofang WangSchool of Pharmaceutical Sciences, Liaoning University, Shenyang 110036, China.
Bin LiuSchool of Pharmaceutical Sciences, Liaoning University, Shenyang 110036, China.

Funding

Central Public-interest Scientific Institution Basal Research Fund ZZ16-ND-10-21Liaoning Revitalization Talents Program XLYC2007054
6 · The paper itself

Abstract

Sonosensitizers play a crucial role in the efficacy of sonodynamic antitumor therapy (SDT) and sonodynamic antimicrobial chemotherapy (SACT), highlighting the necessity for the development of new compounds with good sonodynamic activity. In this study, three novel 3-substituted ciprofloxacin derivatives (CIPD1, CIPD2, and CIPD3) were designed and synthesized. Their sonodynamic activities were evaluated by assessing the damage to bovine serum albumin (BSA) and

Indexed as

CiprofloxacinEscherichia coliReactive Oxygen SpeciesSerum Albumin, BovineAnimalsAnti-Bacterial AgentsUltrasonic WavesAnti-Bacterial AgentsCiprofloxacinReactive Oxygen SpeciesSerum Albumin, Bovinebovine serum albuminciprofloxacin derivativesEscherichia colireactive oxygen speciessonodynamic damagesonosensitizers

Identifiers

PMID39202815
PMCPMC11357595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.